Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. We have developed an entirely novel, powerful and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs.

ARCH Venture Partners

Illumina Ventures

Protillion Biosciences

Excited and honored to see Protillion Biosciences featured in Illumina Ventures company spotlight! Dramatically shortening the therapeutic protein discovery timeline is an exciting and challenging goal, and it's a privilege to contribute to this mission.

#Protillion #InnovationInHealthcare #proteinengineering #antibodydiscovery

Protillion wishes you a very Happy & Pumpkiny Halloween season!

Protillion pumpkins (Protumpkins?) carved most excellently by Michael Gotrik Adriana Arneson David Heiner Jacob Gano Melania Strycharska Lydia Fulton
Artistic display: Adriana Arneson
Picture credit : Melania Strycharska

Protillion is excited to announce that we have moved our headquarters to a  newly built out, spacious facility in Carlsbad! After 4 years in our humble Burlingame home, we are thrilled to begin a new chapter with all of our employees together under the same beautiful roof.

We are excited to welcome Dirk Zajonc as the Head of Antibody Engineering to Protillion! Dirk brings a wealth of academic and industry experience towards antibody engineering and developing therapeutic antibody drug candidates. We greatly look forward to building out the antibody engineering side of our company! 
[Dirk is looking to hire exceptional candidates to his team - look for updates from him]

We are excited to continue growing our teams at Protillion! We have been recently joined by three outstanding, super talented folks: 

Melania Strycharska in Platform Development, 
Adriana Arneson in Bioinformatics, & 
Hwai-En Ho in Engineering
 
We look forward to building the next generation of antibody discovery and therapeutics platforms together!

Also, we are still hiring across a number of teams - visit protillion.com/careers and check us out!

We are excited to welcome Eric Allen to the Protillion fold. Eric is a veteran Bioinformatics and Software Development leader with 20+ years of experience at numerous companies including Illumina and Boundless Bio. Eric will lead the development of world-class scientific software that will power antibody discovery and optimization on our platform. Welcome Eric Allen!


#hiring #software #development #experience

Wavemaker Labs is a venture capital firm that invests in early-stage life science startups, focusing on innovative genomics and precision medicine companies.

Wavemaker Labs

Magic Fund is an independently managed venture capital firm that focuses on early-stage life science startups, with a specific interest in genomics and precision medicine companies.

Magic Fund

InnoSpring is a venture capital firm that invests in genomics and precision medicine companies at an early stage, leveraging a global network and expertise in the life sciences industry.

InnoSpring

BGI is a state-owned sequencing giant that competes with Illumina in the genomics technology sector, known for reverse-engineering Illumina sequencers.

Illumina Ventures is an independently managed venture capital firm focused on early-stage life science startups. The company invests in innovative genomics and precision medicine companies, leveraging the expertise and global network of its strategic partner, Illumina, Inc., a leader in genomics technology.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 14, 2024 5:48 PM	ca9510cb
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	4331dcf2
crunchbase profile	general	Nov 25, 2024 11:38 AM	494ec5c0
li profile	general	May 14, 2024 5:48 PM	a6ef5e58
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ILLUMINAVENTURES

Illumina Ventures